An all-Yale team of researchers successfully treated a patient with disfiguring sarcoidosis, a chronic disease that can affect multiple organs, with a drug approved for rheumatoid arthritis.
All news from Pharmacology and Therapeutics
The U.S. Food and Drug Administration today approved Elzonris (tagraxofusp-erzs) infusion for the treatment of blastic plasmacytoid dendritic cell neoplasm (BPDCN) in adults and in pediatric patients, two years of age and older.
About 3.4 million Americans, or 1.2 % of the population, have active epilepsy. Although the majority respond to medication, between 20 and 40 % of patients with epilepsy, continue to have seizures even after trying multiple anti-seizure drugs.
Chemotherapy is the use of drugs to cure a disease, but more specifically, it refers to drug therapy for cancer. Cancer chemotherapy can be done with a single drug or a combination of drugs and is usually systematic.
A team of researchers from the Singapore University of Technology and Design (SUTD) and Nanyang Technological University (NTU) have developed novel ferrocene-based molecules that impair the malaria parasite's metabolic function leading to parasite death.
Patients with treatment-resistant epilepsy can develop a tolerance to cannabis-based therapy, a finding that may have implications for long-term management, new research suggests.
Research led by Suresh Alahari, Ph.D., Fred Brazda Professor of Biochemistry and Microbiology at LSU Health New Orleans, suggests a novel protein may be a promising therapeutic target to treat or prevent metabolic disorders.
In billions of tiny capsules.An international team has developed a novel pharmaceutical formulation to administer Triclabendazole an anti-parasitic drug used to treat a type of flatworm infection
USC scientists report that a novel time-keeping mechanism within liver cells that helps sustain key organ tasks can contribute to diseases when its natural rhythm is disrupted. This dual function of the nuclear receptor protein HNF4A offers a potential explanation for diseases such as diabetes and cancers.
The relationship between influenza and pneumonia has long been observed by health workers. Its genetic and cellular mechanisms have now been investigated in depth by scientists in a study involving volunteers and conducted in the United Kingdom.
Brian Wainger, MD, of the Healey Center for ALS at Massachusetts General Hospital (MGH) presented initial, top-level results of a recently completed phase 2 clinical trial of ezogabine (also called retigabine) on December 9 at the Motor Neurone Disease Association annual meeting in Glasgow, Scotland.
Ear infections, or "otitis media," can cause of a lot of pain and discomfort in youngsters. In some children, persistent infections result in hearing loss. But what sort of treatment should these children have, and how can doctors work out what is actually effective?